Impact of Pharmacist Intervention on Utilization of SGLT2 Inhibitors in Patients With Heart Failure With an Ejection Fraction Greater than 40%
Published online on December 20, 2025
Abstract
Journal of Pharmacy Practice, Ahead of Print.
Introduction:Heart failure is a leading cause of morbidity and mortality worldwide. Literature suggests that the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors can be beneficial to decrease hospitalizations and cardiac mortality in patients ...
Introduction:Heart failure is a leading cause of morbidity and mortality worldwide. Literature suggests that the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors can be beneficial to decrease hospitalizations and cardiac mortality in patients ...